BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37703478)

  • 1. Increased Uptake of Brown Tumor in 99m Tc-HYNIC-TOC Scintigraphy Mimicking Postoperative Recurrence of Tumor-Induced Osteomalacia.
    Zhang Y; Wang P; Liu M; Liu Y; Jing H
    Clin Nucl Med; 2023 Nov; 48(11):978-979. PubMed ID: 37703478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy.
    Jin X; Jing H; Li F; Zhuang H
    Clin Nucl Med; 2013 Nov; 38(11):922-4. PubMed ID: 24089059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO).
    Jing H; Li F; Zhong D; Zhuang H
    Clin Nucl Med; 2013 Aug; 38(8):664-7. PubMed ID: 23797229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of
    Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
    Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
    Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Carcinoma Shown on 99mTc-HYNIC-TOC Study Performed to Evaluate Tumor-Induced Osteomalacia.
    Jin X; Li F; Chen L; Jing H
    Clin Nucl Med; 2022 Feb; 47(2):197-199. PubMed ID: 34406185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of
    Li B; Duan L; Li X; Shi J; Li H; Liu H; Cheng X; Wu X; Gao Y
    Front Oncol; 2023; 13():1228575. PubMed ID: 37554164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
    Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
    J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
    Czepczyński R; Kosowicz J; Ziemnicka K; Mikołajczak R; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2006; 57(4):431-5. PubMed ID: 17006849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
    Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
    J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-HYNIC-TOC in the Evaluation of Recurrent Tumor-Induced Osteomalacia.
    Shi X; Jing H; Li F; Zhao Y; Wang Z; Huo L
    Clin Nucl Med; 2019 Mar; 44(3):209-213. PubMed ID: 30672760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
    Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
    Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental value of
    Trogrlic M; Težak S
    Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of
    Chen H; Li Y; Gao X; Shen X
    Clin Imaging; 2018; 52():365-369. PubMed ID: 30248495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
    Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
    J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Nodule as Culprit Lesion Causing Recurrent Tumor-Induced Osteomalacia Revealed by 68 Ga-DOTATATE PET/CT.
    Zhang Y; Wang P; Jing H
    Clin Nucl Med; 2023 Sep; 48(9):826-827. PubMed ID: 37486706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hyperplasia shown on (99m)Tc-HYNIC-TOC scan.
    Niu N; Mao X; Jing H; Li F
    Clin Nucl Med; 2013 Apr; 38(4):294-6. PubMed ID: 23455537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcystic Serous Cystadenoma Masquerading as Pancreatic Neuroendocrine Tumor on 99m Tc-HYNIC-TOC SPECT/CT.
    Cai W; Dong Y; Zhao T; Dong A; Zhao Q
    Clin Nucl Med; 2024 Feb; 49(2):e87-e89. PubMed ID: 38048519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
    Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.